Avidity Biosciences Total Liabilities and Share Holders Equity 2019-2024 | RNA

Avidity Biosciences total liabilities and share holders equity for the quarter ending September 30, 2024 was $1.641B, a 186.27% increase year-over-year.

  • Avidity Biosciences total liabilities and share holders equity for 2023 was $0.629B, a 1.6% decline from 2022.
  • Avidity Biosciences total liabilities and share holders equity for 2022 was $0.639B, a 49.4% increase from 2021.
  • Avidity Biosciences total liabilities and share holders equity for 2021 was $0.428B, a 28.06% increase from 2020.

Avidity Biosciences Total Liabilities and Share Holders Equity 2019-2024 | RNA

  • Avidity Biosciences total liabilities and share holders equity for 2023 was $0.629B, a 1.6% decline from 2022.
  • Avidity Biosciences total liabilities and share holders equity for 2022 was $0.639B, a 49.4% increase from 2021.
  • Avidity Biosciences total liabilities and share holders equity for 2021 was $0.428B, a 28.06% increase from 2020.